Indian Journal of Pharmacy and Pharmacology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 11, Issue : 3, Year : 2024
Article Page : 132-140
Abstract
Objectives: Ischemic heart disease stands as the primary cause of death globally, impacting both developed and developing nations alike. Despite a decline in mortality rates in affluent countries, IHD still claims a significant one-third of lives among those aged 35 and above which necessitates urgent comprehensive strategies to mitigate its growing burden on cardiovascular health worldwide. This study aims to evaluate the incidence, risk factors, management, and outcomes of hospitalized IHD cases in a tertiary care setting.
Materials and Methods: Conducted over six months, the prospective cross-sectional study included 303 adult inpatients diagnosed with IHD, excluding pregnant women, psychiatric patients, and children. Data collected from patient records, laboratory tests, and imaging studies were meticulously analysed using statistical software to determine frequencies, percentages, and mean values.
Results: Among 6,897 inpatients observed, IHD cases accounted for 4.39%, predominantly affecting males aged 51-60. Risk factors such as hypertension, diabetes mellitus, smoking, alcohol consumption, and a family history of cardiovascular diseases were prevalent. Non-ST-elevation myocardial infarction (NSTEMI) was the most common presentation, managed primarily with antiplatelet and antihyperlipidemic therapies. Percutaneous coronary intervention with stenting was performed in 92% of surgical cases, resulting in clinical improvement for 92.4% of patients with a low mortality rate of 1.7%.
Conclusion: This study underscores the higher prevalence of IHD in middle-aged males with specific risk factors. It highlights effective treatment outcomes and emphasizes the ongoing need for targeted preventive measures and management strategies to reduce the impact of IHD globally.
Keywords: Ischemic heart disease, Hypertension, Diabetes mellitus, Non-ST-elevation myocardial infarction
How to cite : Salih R, Kunderi N P, Uprety S, Dwivedy S, Kumar E S, Yashaswini P, Padma L, Ischemic heart disease in patients: Incidence, risk factors, management and outcomes in tertiary care hospital. Indian J Pharm Pharmacol 2024;11(3):132-140
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
